Growth Factors Are Proteins — So Why Don’t They Work When You Just Rub Them on Your Scalp? Reading the Molecular Weight, Skin Barrier and Degradation Walls of Stem Cell Conditioned Media2026.06.28

“I’ve been using a scalp tonic with growth factors, but I just don’t feel any change.” It’s one of the most common things I hear in the hair regeneration clinic.

The market is full of scalp products advertising EGF, FGF and other growth factors, but whether those molecules are actually reaching the hair follicle is, medically speaking, a very different story. How we deliver stem cell conditioned media into the scalp is a question we cannot avoid when we talk about hair regenerative medicine.

In this column, I’ll walk through why growth factors don’t really work just by applying them topically, organized around three walls — molecular weight, skin barrier and degradation — and then explain how delivery should actually be designed.

Growth factors are not the kind of molecule that “just gets through” when you put them on the skin

Most growth factors are proteins built from tens to hundreds of amino acids. EGF is roughly 6,000 daltons, FGF roughly 17,000 daltons, and HGF goes up to about 80,000 daltons — all of them are, by drug delivery standards, fairly large molecules.

Meanwhile, the outermost layer of our skin, the stratum corneum, is a tightly packed barrier of keratin and lipids. The classical rule of skin pharmacology is that only small molecules — roughly under 500 daltons — pass through it easily.

In other words, structurally speaking, growth factors cannot really cross the stratum corneum when you just rub them onto the scalp. This is the first reason stem cell conditioned media should not be treated like a simple lotion you dab on at home.

The first wall: molecular weight versus the skin barrier

The stratum corneum is built like a brick wall, with 15 to 20 layers of flattened cells held together by lipid mortar, strongly restricting both water loss and the entry of outside substances.

A representative topical drug that does pass this barrier is minoxidil, with a molecular weight of about 209 daltons. It is precisely because it is so small that it can reach the follicle from a topical formulation.

EGF and FGF are an order of magnitude larger. Most of them sit on the surface of the scalp or are washed away with sebum. The feeling that “I’m applying it but it isn’t doing anything” is not an illusion.

The second wall: tight junctions

Even if some of the molecule slips past the stratum corneum, the granular layer underneath has structures called tight junctions, which once again repel large molecules.

The follicular opening (the infundibulum) is known to have a relatively weak barrier, and there is a small route of penetration via the pore, but the capacity is limited and it’s not realistic to expect even distribution across the whole scalp.

To bring the EGF, FGF, IGF-1, VEGF and HGF family of factors carried by stem cell conditioned media down to the follicle, we need a way to temporarily get past the skin barrier itself.

The third wall is degradation — even what gets in doesn’t stay

Even if a growth factor reaches the deeper layers of the skin, there is another major obstacle. Proteins are rapidly broken down by enzymes in the body.

Inactivation by proteases

Proteases — enzymes that break down proteins — are constantly working in the skin and in the bloodstream. The plasma half-life of injected growth factors is known to be on the order of minutes to tens of minutes, and locally in the scalp they similarly lose activity in the tissue fluid over time.

For this reason, stimulating the follicle is medically better served by a protocol of “delivering an appropriate dose repeatedly at proper intervals” than by trying to push in a huge amount at once. The reason frequency design matters so much in stem cell conditioned media therapy is exactly this pharmacokinetic reality.

Stability of the preparation and storage conditions

We also cannot ignore the stability of the conditioned media itself. Growth factors lose structure and activity when subjected to repeated freeze–thaw, long exposure at room temperature, or direct sunlight.

No matter how high the original concentration of a stem cell conditioned media product is, if the temperature control (the cold chain) from distribution to the moment of treatment is not maintained, it cannot perform at full strength when it enters the scalp. The fact that “the same product seems to work differently on different days” often hides exactly this kind of quality variability.

So how should stem cell conditioned media actually be delivered into the scalp?

Putting all of this together, it is, in principle, very difficult to deliver growth factors to the follicle by topical application alone. That is why medical facilities use approaches that physically open the skin barrier for a short time.

Microneedling and Morpheus8 as drug delivery

Microneedling with a derma pen, or Morpheus8, which combines microneedling with radiofrequency, creates transient channels through the stratum corneum and into the deeper layers using extremely fine needles. Delivering stem cell conditioned media through these channels bypasses the two walls — molecular weight and stratum corneum — that topical use cannot cross.

In addition, the microinjuries themselves trigger a wound-healing signal (endogenous release of growth factors and cytokines), which is thought to act synergistically with the externally supplied conditioned media.

For the medical framework of AGA treatment, the guidelines from the Japanese Dermatological Association are a useful reference to clarify the roles of oral medication, topical medication and regenerative medicine.

Scalp injection as a reliable delivery route

The other approach is to inject stem cell conditioned media directly into the dermis or the shallow subcutaneous layer of the scalp with a very fine needle. This completely bypasses the skin barrier and is the most reliable route in terms of getting the growth factors to where they need to go.

On the other hand, pain, bruising and operator-dependent variability are more pronounced, so in practice it is realistic to combine it with needling-based drug delivery or to choose between them on a case-by-case basis.

Whichever route is chosen, the first step toward results is sharing the premise that “just applying it does not deliver it” before designing the treatment.

Summary: don’t confuse “applying” with “delivering”

Because growth factors are proteins, they are blocked by three walls — molecular weight, skin barrier and degradation. So the true value of stem cell conditioned media is decided not only by what is in the bottle but also by how it is delivered into the scalp.

Rather than relying on topical use as a half-measure, what really matters as regenerative medicine for the follicle is the combination of a medical delivery method that crosses the skin barrier, a properly designed frequency, and a quality-controlled stem cell conditioned media product.

If you’d like to explore further, please also see our related hair regenerative medicine columns.

──────────────

Supervising physician: Shin Moriwaki, MD

Member, Japan Society of Aesthetic Surgery (JSAS) / Member, American Academy of Aesthetic Medicine

ECFMG certificate (US medical licensing qualification)

──────────────

📍AVAN TOKYO Ginza Hair Regenerative Medicine

English / 中文 / Tiếng Việt available

Consultations via DM / LINE / Website / Phone.